Alkem is transforming every aspect of its business. A transformation that will unleash a bigger tomorrow for all its stakeholders. In an era of relentless change, organisations survive, grow and thrive based on their ability to embrace change. Alkem’s clear commitment to repositioning itself from time to time has enabled it to create a powerful future.
What is the vision?
Alkem Laboratories has the vision to achieve value-driven leadership in the Indian Healthcare Industry and beyond through: Quality that is infinite, service that cares and hard work that endures.
In an era of relentless change, organisations survive, grow and thrive based on their ability to embrace change. Alkem’s clear commitment to repositioning itself from time to time has enabled it to create a powerful future.
Among India’s leading global pharmaceutical companies, Alkem Laboratories is engaged in the development, manufacturing and marketing of pharmaceutical products. The pharmaceutical industry is subject to extensive, complex and evolving regulations.
Also Read: CSR: Omega to Train 10,000 Youth from marginalised communities
The Company produces high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals. These products are sold in India and internationally and include over 800 brands covering all the major therapeutic segments.
Since its inception in 1973, Alkem has consistently aligned its capabilities and expanded its presence to capture new growth areas and grow sustainably. Today, powered by these strengths, it ranks among India’s top ten pharmaceutical companies. The Company has set up 20 state-of-the-art manufacturing facilities and 6 R&D centres across multiple locations in India and the United States, its key overseas market.
The R&D efforts are directed toward bringing affordable, high-quality products to the market to expand patient access to healthcare. Over the years, the Company has also developed a robust pan-India sales and distribution network, invested in brand building and marketing, and built a large and talented workforce to scale up growth.
Alkem is also a leading player in the acute therapeutic segment in India. Led by systematic planning for the future and the foresight to tap new growth opportunities, the product portfolio has been expanded to serve select fast-growing chronic therapeutic areas.
Entering new growth markets is another facet underpinning Alkem’s transformation journey. Besides the US, which is its second-largest market, the Company has a growing presence in over 40 countries, including the key markets of Australia, Chile, Philippines, Kazakhstan, Europe and East Africa.
It has 20 manufacturing facilities at multiple locations in India and the United States of America. The upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA – UK, SAHPRA-South Africa, TGA – Australia, ANVISA – Brazil, WHO – Geneva, TPD – Health Canada, PPB – Kenya, NDA – Uganda, MOH – Sudan, INVIMA – Colombia, TFDA – Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.
Also Read: How to Apply for a Personal Loan if You Have a Low Credit Score
Another feather in the cap was added on December 23rd, 2015, when, Alkem completed its Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.
Although, passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 6 global R&D centers, It is empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
